Tuesday, 15 Jul 2008 | Source: The Associated Press
Continued demand for drug research and development tools has likely translated into strong second-quarter profit for life-sciences companies, which begin reporting financial results next week.
The old adage advises investors to "sell in may and go away," but CNBC asked the experts for stock picks that might that might make investors stay in the game this month.
Recent gains in the markets have changed the valuation picture on a lot of stocks, but Jefferies managing director Art Hogan is constantly on the lookout for bargains, and he told CNBC about some stocks that are still steals.... Read More